Yatharth Hospital and Trauma Care Services Limited (YATHARTH) AI Stock Analysis

• Market Cap: ₹64.89B
• Dividend Yield: N/A
• Average Volume (3M): 28.98K
• Price to Earnings (P/E): 36.2
• Beta (1Y): 1.19
• Revenue Growth: 27.65%
• EPS Growth: 4.02%
• Country: IN
• Employees: 3,607
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): 4.71
• Shares Outstanding: 96,354,355
• 10 Day Avg. Volume: 38,534
• 30 Day Avg. Volume: 28,985
• PEG Ratio: 15.52
• Price to Book (P/B): 2.27
• Price to Sales (P/S): 4.14
• P/FCF Ratio: -22.60
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 20.58
• Revenue Forecast (FY): ₹12.01B

• Rating: 66 Neutral
• Price Target: ₹660.00 ▼(-5.69% Downside)
• Action: Downgraded Date: 11/30/25
• Date: Action: Downgraded 11/30/25

Yatharth Hospital's strong financial performance, characterized by revenue growth and improved profitability, is the most significant factor driving the stock score. However, technical indicators suggest short-term bearish momentum, and the high P/E ratio points to potential overvaluation. The absence of earnings call insights and corporate events limits the analysis to these core components.

Positive Factors

Revenue growth & margin strength

Sustained revenue expansion combined with high gross margins indicates durable demand for hospital services and effective cost control. Over 2–6 months this supports reinvestment in capacity and margins resilience, enabling scaling without proportionate margin dilution.

Improved balance sheet / lower leverage

A stronger equity base and reduced leverage improve financial flexibility and lower solvency risk. This durable improvement increases capacity to fund expansion, negotiate better terms with lenders, and absorb operating shocks during the medium term.

Operating cash flow turnaround

Positive operating cash flow signals the core hospital business is generating cash from operations rather than relying solely on financing. That strengthens liquidity and supports funding of working capital and ongoing investments over the next several quarters.

Negative Factors

Negative free cash flow due to capex

Persistent negative free cash flow driven by heavy capex means the company must rely on external financing or equity to fund growth. Over 2–6 months continued negative FCF can pressure liquidity, restrict distributions, and raise refinancing and funding risks.

Potential over-leverage from rapid asset growth

Rapid asset expansion outpacing liability growth can mask funding concentration or asset quality issues. If asset growth is financed aggressively, solvency metrics could deteriorate with slower cash conversion, increasing financial risk in the medium term.

Compression in operating efficiency

A declining EBIT margin, even amid revenue growth, indicates rising operating costs or margin pressure. Without efficiency gains or better case mix, margin compression could limit net profitability expansion and undermine long-term returns on incremental revenue.

Yatharth Hospital and Trauma Care Services Limited Business Overview & Revenue Model

Company Description

Yatharth Hospital & Trauma Care Services Limited owns and operates super-specialty hospitals in Delhi and Madhya Pradesh. The company offers services in the areas of gynecology; gastroenterology; pulmonology; pediatric; nephrology and urology; cardiology; orthopedics and spine and rheumatology; neurosciences; medicine; general surgery; ENT; physiotherapy and rehabilitation; interventional spine and pain medicine; nutrition and health; pathology and laboratory medicine; dentistry; ophthalmology; dermatology; anesthesiology; radiology; and psychology and psychiatry. The company was incorporated in 2008 and is based in Noida, India.

How the Company Makes Money

Yatharth Hospital generates revenue primarily through patient services, which include inpatient admissions, outpatient consultations, surgeries, and diagnostic services. The hospital charges fees for various medical services rendered, which are often covered by health insurance plans, contributing significantly to its income. Additionally, YATHARTH may generate revenue through partnerships with insurance companies and government health programs that reimburse for treatments provided to insured patients. Other potential revenue streams could include ancillary services such as pharmacy sales, laboratory tests, and wellness programs. The hospital's focus on quality care and its reputation in the community also play crucial roles in attracting more patients and thereby increasing its earnings.

Yatharth Hospital and Trauma Care Services Limited Financial Statement Overview

Summary

Yatharth Hospital is on a strong growth trajectory with improving profitability and solid revenue expansion. The company's enhanced equity position and reduced leverage are positive signs. However, the ongoing negative free cash flow due to capital expenditures highlights the need for careful investment management to maintain financial stability.

Income Statement

Yatharth Hospital has demonstrated strong revenue growth, with a significant increase from 2020 to 2025. The gross profit margin is consistently high, indicating efficiency in cost management. Net profit margin has improved, showcasing enhanced profitability. However, the slight drop in EBIT margin over the years suggests room for operational efficiency improvements.

Balance Sheet

The company's debt-to-equity ratio has improved significantly, reflecting a stronger equity base and reduced leverage. The substantial increase in stockholders' equity indicates robust growth in assets relative to liabilities. However, the high increase in total assets compared to liabilities suggests potential over-leverage if not managed properly.

Cash Flow

Operating cash flow has improved from negative to positive, signifying better cash management. However, free cash flow remains negative due to high capital expenditures, indicating ongoing investments in growth. The operating cash flow to net income ratio has improved, but sustaining this trend is crucial for long-term financial health.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	9.88B	8.80B	6.71B	5.20B	4.01B	2.29B
Gross Profit	6.73B	5.39B	5.37B	4.27B	3.20B	1.82B
EBITDA	2.69B	2.36B	1.96B	1.37B	1.13B	675.27M
Net Income	1.52B	1.31B	1.14B	657.68M	441.62M	181.60M
Balance Sheet
Total Assets	18.56B	17.31B	10.19B	4.86B	4.26B	3.09B
Cash, Cash Equivalents and Short-Term Investments	2.83B	5.15B	2.39B	382.36M	120.31M	51.52M
Total Debt	262.33M	115.86M	846.47M	2.67B	2.64B	1.93B
Total Liabilities	1.36B	940.45M	1.45B	3.03B	3.09B	2.28B
Stockholders Equity	16.89B	16.05B	8.74B	1.83B	1.17B	724.55M
Cash Flow
Free Cash Flow	-1.49B	-1.61B	-964.43M	439.70M	468.01M	235.38M
Operating Cash Flow	485.14M	1.50B	-30.78M	637.84M	599.35M	436.73M
Investing Cash Flow	-2.51B	-4.20B	-2.26B	-203.10M	-521.75M	-212.38M
Financing Cash Flow	142.57M	5.19B	3.04B	-177.48M	-11.24M	-190.50M

Yatharth Hospital and Trauma Care Services Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 699.80
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:YATHARTH, the sentiment is Positive. The current price of 699.8 is above the 20-day moving average (MA) of 682.25, above the 50-day MA of 652.85, and above the 200-day MA of 682.80, indicating a neutral trend. The MACD of 0.07 indicates Positive momentum. The RSI at 51.00 is Neutral, neither overbought nor oversold. The STOCH value of 43.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:YATHARTH.

Yatharth Hospital and Trauma Care Services Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HCG	67 Neutral	₹84.71B	-247.47	―	―	17.58%	-38.20%
YATHARTH	66 Neutral	₹64.89B	36.23	―	―	27.65%	4.02%
KIMS	65 Neutral	₹269.25B	114.01	―	―	25.74%	1.41%
INDRAMEDCO	64 Neutral	₹37.25B	25.06	―	0.96%	6.51%	18.24%
ASTERDM	62 Neutral	₹342.87B	151.95	―	0.84%	-36.14%	-93.99%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SHALBY	50 Neutral	₹15.68B	310.39	―	0.59%	11.49%	-91.65%

Yatharth Hospital and Trauma Care Services Limited Corporate Events

Yatharth Hospital Releases Q2 FY26 Financial Results

Yatharth Hospital & Trauma Care Services Limited has released its Q2 FY26 financial results through an investor presentation. This announcement is part of the company’s compliance with regulatory requirements and aims to inform stakeholders about its financial performance, potentially impacting its market positioning and investor relations.

Yatharth Hospital Appoints New Independent Director to Strengthen Board

Yatharth Hospital and Trauma Care Services Limited has appointed Mr. Ramesh Krishnan as an Additional Director (Non-Executive Independent) effective from November 5, 2025, for a five-year term, subject to shareholder approval. This strategic appointment is part of the company’s efforts to strengthen its board with experienced leadership, potentially enhancing its governance and strategic direction.